bioRxiv Science⌕ Search

bioRxiv · 10.1101/2024.12.31.630890

Trogocytosis-mediated transfer of FOLR2 from Nurse-like cells to CLL cells is linked to their activation and proliferation

Abstract

Communication with the lymphoid microenvironment is crucial for survival and proliferation of neoplastic B cells in chronic lymphocytic leukemia (CLL). In this study, we examined nurse-like cells (NLCs), CLL-specific macrophages, strongly implicated in CLL pathogenesis, and their interaction with leukemic cells. Using primary patient cells, we demonstrated that NLCs express high levels of folate receptor beta (FOLR2), which correlates with increased survival of cancer cells in vitro. Furthermore, we discovered that CLL cells acquire functional FOLR2 from NLCs via trogocytosis, enhancing their folate uptake. By mimicking the CLL microenvironment with soluble factors, CD40L and IL-15, we observed a strong NLC-dependent CLL cell activation and proliferation. Moreover, we linked this phenomenon with trogocytosis, by demonstrating that FOLR2+ CLL cells are the predominant population of actively cycling cancer cells. By multiplex immunofluorescence analysis of CLL patient lymph nodes, we confirmed the presence of FOLR2 NLCs, and observed their enrichment in more aggressive and proliferative CLL cases. Finally, we detected FOLR2 cancer cells, providing evidence of trogocytosis in situ. Taken together, we propose FOLR2 as a novel marker of protective NLCs, and highlight the importance of trogocytosis in improved CLL cell adaptation, including NLC-mediated activation and proliferation. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=58 SRC="FIGDIR/small/630890v3_ufig1.gif" ALT="Figure 1"> View larger version (22K): org.highwire.dtl.DTLVardef@1cde6d6org.highwire.dtl.DTLVardef@ee0f67org.highwire.dtl.DTLVardef@1355cb3org.highwire.dtl.DTLVardef@590b29_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOScheme 1.C_FLOATNO Schematic representation of trogocytosis-mediated acquisition of NLC-derived FOLR2 by CLL cells, and its impact on promoting cancer cell adaptability to folate deprivation. 1) CLL cells enter the lymph node (LN) and engage in contact with FOLR2+ NLCs. 2) The presence of T cell- and stromal cell-derived cytokines, CD40L and IL-15 promotes the activation and trogocytosis-mediated acquisition of FOLR2 by CLL cells. 3) FOLR2 trogocytic CLL cells have an advantage in folate acquisition and show increased proliferation compared to the remaining population of cancer cells C_FIG SUMMARYO_LICLL cells acquire functional FOLR2 from NLCs via trogocytosis, a process that is closely linked with enhanced CLL cell activation and proliferation in vitro C_LIO_LIIncreased Frequency of FOLR2 expressing macrophages in more aggressive and proliferative cases of CLL. C_LIO_LIFOLR2 is a marker of M2-like protective NLCs in vitro C_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Domagala, M., Gerby, B., Bazile, C., Ysebaert, L., Pancaldi, V., Laurent, C., Poupot, M.. 2025-01-02. Trogocytosis-mediated transfer of FOLR2 from Nurse-like cells to CLL cells is linked to their activation and proliferation. https://doi.org/10.1101/2024.12.31.630890

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Epigenetic progression of pancreatic cancer to aggressive subtypes involves alternate routes of lineage reprogramming in subtype-intermediate progenitor cells

Pancreatic ductal adenocarcinoma (PDAC) progression involves malignant cell state plasticity. Epigenetic changes underlie this plasticity, yet the PDAC cis-regulatory landscape remains understudied. To address this, we profiled 33 primary tumors and 7 metastases from 39 patients with single-cell ATAC-seq, paired with 10 single-cell RNA-seq profiles. We found that epigenetic GATA6+/KRT17+ co-accessibility identifies a classical-basal subtype-intermediate progenitor state (SIP) associated with better clinical outcomes. SIP cells display limited epigenetic reprogramming from premalignant epithelium and retain gastric-intestinal differentiation reminiscent of neoplastic precursors. Lineages without GATA6+/KRT17+ co-accessibility exhibit greater lineage and epithelial-mesenchymal plasticity. Classical PDACs that repress basal gene accessibility activate neural-like progenitor (NRP) and tuft lineage enhancers, whereas basal committed tumors display esophageal transdifferentiation. Compared to SIP, classical-NRP and basal committed tumors have poorer outcomes, and show distinct PD-1/PD-L1 immune proteomic phenotypes and prognostic myofibroblast epigenetic states, respectively. Our work reveals links between lineage reprogramming, EMT, and epigenetic progression in human PDAC.

cancer biology↗

Tissue resident CD4+ memory T-cells mark response to immune checkpoint inhibition in high-grade glioma

Background: Immune checkpoint inhibitors (ICI) are efficacious in many solid tumors, but response in glioma is restricted to a small subgroup. The determinants of response and resistance to ICI remain poorly understood. Methods: Here we exploit a syngeneic hypermutated high-grade glioma model with dichotomous response to combined PD-1 and CTLA-4 inhibition to unravel determinants of tumor-infiltrating T-cells driving response. Tumor-infiltrating T-cells from ICI-responsive and non-responsive tumors were analyzed by single-cell RNA and T-cell receptor sequencing and tumor-reactive T-cell receptor clonotypes were functionally validated to characterize their transcriptional phenotypes. We verify our findings in IDH1 wildtype glioblastoma patients treated with neoadjuvant pembrolizumab. Results: ICI response was associated with intratumoral clonal expansion of tumor-reactive cytotoxic T-cells and increased infiltration of CXCR6+ CD4+ tissue resident memory T-cells (Trm). CD4 stem-like memory T-cells in responding tumors demonstrated elevated interferon responses, following trajectories toward clonally expanded Trm, versus trajectories toward exhaustion in non-responsive tumors. In responsive tumors, CD4+ Trm interacted with infiltrating CXCR3+ tumor-reactive and clonally expanded, yet transcriptionally versatile cytotoxic T-cells. Probing the post neoadjuvant ICI high-grade glioma patient tissue dataset, we confirmed increased CXCR6 expression in CD4+ T cells and the association of CD4+ Trm with prolonged overall survival. Conclusion: These findings identify CD4 tissue-resident memory T-cells as determinants of ICI response in IDH1 wildtype high-grade glioma and warrant their further investigation to improve immunotherapy outcomes.

cancer biology↗

Low-dose doxorubicin drives caveolin-1 depended re-epithelialization of breast cancer cells as a mechanism of cancer plasticity

Breast cancer progression is driven by dynamic changes in epithelial plasticity, membrane organization, and intracellular signaling, yet the effects of sustained low-dose chemotherapy on these processes remain poorly understood. Here, we investigated the impact of prolonged low-dose doxorubicin on membrane remodeling, epithelial phenotype, membrane-associated Ras lipid-anchor localization, and autophagy in mesenchymal-like MDA-MB-231 breast cancer cells. Low-dose doxorubicin significantly increased Caveolin-1 expression and enhanced E-cadherin protein levels, accompanied by a transition toward a more compact epithelial-like morphology with increased cell-cell contacts. Live-cell imaging demonstrated a significant reduction in the membrane-to-cytoplasm fluorescence ratio of the lipid-anchored GFP-tH probe, indicating redistribution from the plasma membrane to the cytoplasm following treatment. Analysis of autophagy-related proteins revealed decreased LC3-I together with increased LC3-II, ATG5, and p62 expression, consistent with autophagosome accumulation and impaired autophagic flux. Collectively, our findings demonstrate that low-dose doxorubicin promotes extensive remodeling of plasma membrane organization, epithelial plasticity, membrane-associated lipid-anchor localization, and autophagy. This integrated response reveals previously unrecognized links between membrane architecture, Ras membrane association, and autophagy during phenotypic reprogramming of breast cancer cells, providing mechanistic insight into cellular adaptations elicited by sub-cytotoxic doxorubicin exposure.

cancer biology↗